Rochefort provides strategic financing to INTALUS for US manufacturing
INTALUS, which developed ceramic infusion for metals, will use the financing to build U.S. hot isostatic pressing and infusion capacity; the amount was not disclosed.
- Target
- INTALUS
- Investor
- Rochefort Asset Management
- Sponsor
- Rochefort Asset Management
Rochefort Asset Management, a national security-focused investment firm licensed under the U.S. Department of War's Office of Strategic Capital and the Small Business Administration, announced strategic financing for INTALUS Inc. The amount and the form of the financing were not disclosed.
INTALUS is an American advanced materials company that developed a ceramic infusion process for metals and has advanced its densification process. The financing will fund U.S. facilities and machinery for its HIP+ system, which densifies metal components, and its Targeted Phase Infusion systems, which infuse ceramic-metal technology into targeted areas of components. The company says the components could serve submarines, space, energy, munitions, nuclear systems and aerospace turbines.
Kyle Bass, co-founder of Rochefort, said the U.S. industrial base needs domestic capacity to manufacture stronger components. INTALUS CEO and co-founder Gene Skiba said the support will allow the company to expand U.S. production.
Background
- Business
- Advanced materials company developing metal-ceramic components and hot isostatic pressing (HIP+) capacity
- Deal type
- Investment
Sources
- PR NewswireNov 10, 2026
Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.